Page last updated: 2024-11-08

2-hydroxyestradiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-hydroxyestradiol: catechol estrogen; RN given refers to (17 beta)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-hydroxy-17beta-estradiol : A 2-hydroxy steroid that consists of 17beta-estradiol having an additional hydroxy group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID247304
CHEMBL ID467987
CHEBI ID28744
SCHEMBL ID225052
MeSH IDM0041560

Synonyms (74)

Synonym
BIDD:ER0098
MLS000069506 ,
smr000058615
CHEBI:28744 ,
2-hydroxy-17beta-estradiol
LMST02010027
SGCUT00102
estra-1,3,5(10)-triene-2,3,17beta-triol
brn 2219367
nsc 61711
estra-1,5(10)-triene-2,3,17-triol, (17.beta.)-
nsc61711
estra-1,5(10)-triene-2,3,17.beta.-triol
2-oh-e2
nsc-61711
ECS ,
2,3,17beta-trihydroxy-1,3,5(10)-estratriene
(17beta)-estra-1,3,5(10)-triene-2,3,17-triol
estra-1,3,5(10)-triene-2,3,17-triol, (17beta)-
estra-1,3,5(10)-triene-2,3,17-beta-triol
2-oh-estradiol
2-hydroxyestradiol-17beta
C05301
362-05-0
2-hydroxyestradiol
2-hydroxyestradiol, >=95% (hplc)
TO_000058
2BW7
2-hydroxy-estradiol ,
2-hydroxy estradiol
DB07706
cid_247304
bdbm50262140
CHEMBL467987 ,
(8r,9s,13s,14s,17s)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-2,3,17-triol
NCGC00247034-01
4-06-00-07547 (beilstein handbook reference)
ccris 8709
unii-ayu2l67yuu
ayu2l67yuu ,
HMS2230J22
EPITOPE ID:159258
estradiol metabolite (2-hydroxyestradiol)
SCHEMBL225052
1,3,5(10)-estratriene-2,3,17beta-triol
estra-1,3,5(10)-triene-2,3,17-triol, (17.beta.)-
estra-1,3,5(10)-triene-2,3,17.beta.-triol
estra-1,3,5(10)-triene-2,3,17-triol #
HMS3648A04
OPERA_ID_1837
estra-1,3,5(10)-triene-2,3,17-triol
1,3,5(10)-estratriene-2,3-17beta-triol
DTXSID3022372
2-hydroxyestradiol, analytical standard
(17b)-estra-1,3, 5(10)-triene-2,3,17-triol
2,3,17b-trihydroxyestra-1,3,5(10)-triene
estra-1,3,5(10)-triene-2,3,17b-triol
estra-1,3,5 (10)-triene-2,3,17.beta.-triol
(17beta)- estra-1,3, 5 (10)-triene-2,3,17-triol
17beta-2-hydroxyestradiol
estra-1,3,5(10)-triene-2,3,17-triol (acd/name 4.0)
(9beta,13alpha,14beta,17alpha)-estra-1,3,5(10)-triene-2,3,17-triol
2-hydroxy-17|a-estradiol
Q27096924
sr-01000946341
SR-01000946341-1
(8r,9s,13s,14s,17s)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthrene-2,3,17-triol
2-hydroxy-17-beta-estradiol 100 microg/ml in acetonitrile
MS-24123
2-hydroxy-17?-estradiol
CS-0086658
HY-124489
PD005535
(1s,3as,3br,9bs,11as)-11a-methyl-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h,11ah-cyclopenta[a]phenanthrene-1,7,8-triol

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response of DHT was biphasic in the presence and absence of FSH, such that progesterone production in the presence of 8 micrograms/ml DHT was similar to basal progesterone production."( Comparative effects of androgens and catecholestrogens on progesterone production by porcine granulosa cells.
Hammond, JM; Spicer, LJ, 1988
)
0.27
" The dose-response profile for renal CYP1A1 parallels that in the liver of either species but EROD-activities are 10-20 times lower than in the liver."( Different mechanisms of handling ingested polycyclic aromatic hydrocarbons in mammalian species: organ-specific response patterns of CYP1A1-induction after oral intake of PAH-contaminated soils.
Hack, A; Roos, PH; Tschirbs, S; Welge, P; Wilhelm, M, 2004
)
0.32
" The model of HCO(3)(-) inhibiting osteoclast via sAC was further supported by the fact that the HCO(3)(-) dose-response on osteoclasts is flat when cells were saturated with 8-bromo-cAMP, a permeant cAMP analog downstream from sAC thus simulating sAC activation."( Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase.
Geng, W; Hill, K; Kohler, T; Moe, OW; Müller, R; Zerwekh, JE, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
prodrugA compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
2-hydroxy steroidAny hydroxy steroid carrying a hydroxy group at position 2.
17beta-hydroxy steroidA 17-hydroxy steroid in which the hydroxy group at position 17 has a beta-configuration.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Estrogen metabolism025

Protein Targets (50)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency0.44670.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency9.89630.140911.194039.8107AID2451; AID2787
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency12.58930.631035.7641100.0000AID504339
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency31.62280.177814.390939.8107AID2147
LuciferasePhotinus pyralis (common eastern firefly)Potency7.56860.007215.758889.3584AID588342
glp-1 receptor, partialHomo sapiens (human)Potency28.18380.01846.806014.1254AID624417
thioredoxin reductaseRattus norvegicus (Norway rat)Potency35.48130.100020.879379.4328AID588453
phosphopantetheinyl transferaseBacillus subtilisPotency10.37360.141337.9142100.0000AID1490; AID2701; AID2707
GLS proteinHomo sapiens (human)Potency8.91250.35487.935539.8107AID624170
TDP1 proteinHomo sapiens (human)Potency17.35820.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency14.12540.180013.557439.8107AID1460
thioredoxin glutathione reductaseSchistosoma mansoniPotency5.62340.100022.9075100.0000AID485364
Smad3Homo sapiens (human)Potency35.48130.00527.809829.0929AID588855
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency14.12540.707912.194339.8107AID720542
hypothetical protein, conservedTrypanosoma bruceiPotency4.28880.223911.245135.4813AID624173; AID720569; AID720584
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency63.09570.707936.904389.1251AID504333
pyruvate kinaseLeishmania mexicana mexicanaPotency3.43840.398113.744731.6228AID1721; AID1722; AID2559
IDH1Homo sapiens (human)Potency16.36010.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency8.91250.035520.977089.1251AID504332
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency3.13810.036619.637650.1187AID2100
fructose-bisphosphate aldolase AOryctolagus cuniculus (rabbit)Potency63.09570.891316.576239.8107AID2794
chromobox protein homolog 1Homo sapiens (human)Potency17.78280.006026.168889.1251AID540317
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency112.20203.548119.542744.6684AID743266
pyruvate kinase PKM isoform aHomo sapiens (human)Potency0.35480.04017.459031.6228AID1631; AID1634
DNA polymerase betaHomo sapiens (human)Potency2.23870.022421.010289.1251AID485314
mitogen-activated protein kinase 1Homo sapiens (human)Potency8.91250.039816.784239.8107AID1454
flap endonuclease 1Homo sapiens (human)Potency89.12510.133725.412989.1251AID588795
ras-related protein Rab-9AHomo sapiens (human)Potency6.30960.00022.621531.4954AID485297
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency21.19230.168316.404067.0158AID720504
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency1.12200.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency1.12200.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency1.12200.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency12.58930.00798.23321,122.0200AID2546; AID2551
gemininHomo sapiens (human)Potency20.02720.004611.374133.4983AID624296; AID624297
DNA dC->dU-editing enzyme APOBEC-3G isoform 1Homo sapiens (human)Potency7.07950.058010.694926.6086AID602310
lamin isoform A-delta10Homo sapiens (human)Potency17.78280.891312.067628.1838AID1487
Endothelin receptor type BRattus norvegicus (Norway rat)Potency0.56230.562315.160931.6228AID1721
Endothelin-1 receptorRattus norvegicus (Norway rat)Potency0.56230.562315.160931.6228AID1721
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency4.72280.060110.745337.9330AID485367; AID504636; AID504637
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonasePlasmodium bergheiIC50 (µMol)27.96670.889021.028671.5000AID504765; AID540252; AID540269
glucose-6-phosphate 1-dehydrogenase isoform bHomo sapiens (human)IC50 (µMol)72.50008.870012.851817.8000AID504792
Androgen receptorRattus norvegicus (Norway rat)IC50 (µMol)8.51140.00101.979414.1600AID255211
Disabled homolog 2-interacting proteinHomo sapiens (human)Ki1.26001.26001.26001.2600AID1618265
Adenylate cyclase type 10Homo sapiens (human)IC50 (µMol)3.00001.10002.05003.0000AID366252
large T antigenBetapolyomavirus macacaeIC50 (µMol)100.00000.160024.9724100.0000AID1903
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Hsf1 proteinMus musculus (house mouse)EC50 (µMol)4.07100.160024.4900236.5000AID435004
Estrogen receptorHomo sapiens (human)EC50 (µMol)1.08200.00000.53054.4000AID103552; AID68712
Estrogen receptor betaHomo sapiens (human)EC50 (µMol)1.08200.00000.47954.8900AID103552; AID68712
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Hsf1 proteinMus musculus (house mouse)AbsAC40_uM25.20001.240012.460025.2000AID602296
hypothetical protein CAALFM_CR05890CACandida albicans SC5314AC509.63001.550013.003854.7000AID588764
H3 histone acetyltransferaseCandida albicans SC5314AC509.63001.550013.003854.7000AID588764
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (132)

Processvia Protein(s)Taxonomy
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
antral ovarian follicle growthEstrogen receptorHomo sapiens (human)
epithelial cell developmentEstrogen receptorHomo sapiens (human)
chromatin remodelingEstrogen receptorHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
signal transductionEstrogen receptorHomo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayEstrogen receptorHomo sapiens (human)
positive regulation of cytosolic calcium ion concentrationEstrogen receptorHomo sapiens (human)
androgen metabolic processEstrogen receptorHomo sapiens (human)
male gonad developmentEstrogen receptorHomo sapiens (human)
negative regulation of gene expressionEstrogen receptorHomo sapiens (human)
positive regulation of phospholipase C activityEstrogen receptorHomo sapiens (human)
intracellular steroid hormone receptor signaling pathwayEstrogen receptorHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptorHomo sapiens (human)
response to estradiolEstrogen receptorHomo sapiens (human)
regulation of toll-like receptor signaling pathwayEstrogen receptorHomo sapiens (human)
negative regulation of smooth muscle cell apoptotic processEstrogen receptorHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionEstrogen receptorHomo sapiens (human)
negative regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
response to estrogenEstrogen receptorHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
fibroblast proliferationEstrogen receptorHomo sapiens (human)
positive regulation of fibroblast proliferationEstrogen receptorHomo sapiens (human)
stem cell differentiationEstrogen receptorHomo sapiens (human)
regulation of inflammatory responseEstrogen receptorHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
RNA polymerase II preinitiation complex assemblyEstrogen receptorHomo sapiens (human)
uterus developmentEstrogen receptorHomo sapiens (human)
vagina developmentEstrogen receptorHomo sapiens (human)
prostate epithelial cord elongationEstrogen receptorHomo sapiens (human)
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesisEstrogen receptorHomo sapiens (human)
regulation of branching involved in prostate gland morphogenesisEstrogen receptorHomo sapiens (human)
mammary gland branching involved in pregnancyEstrogen receptorHomo sapiens (human)
mammary gland alveolus developmentEstrogen receptorHomo sapiens (human)
epithelial cell proliferation involved in mammary gland duct elongationEstrogen receptorHomo sapiens (human)
protein localization to chromatinEstrogen receptorHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptorHomo sapiens (human)
negative regulation of miRNA transcriptionEstrogen receptorHomo sapiens (human)
regulation of epithelial cell apoptotic processEstrogen receptorHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptorHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIDisabled homolog 2-interacting proteinHomo sapiens (human)
angiogenesisDisabled homolog 2-interacting proteinHomo sapiens (human)
inflammatory responseDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of cell population proliferationDisabled homolog 2-interacting proteinHomo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of endothelial cell migrationDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of epithelial cell migrationDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of epithelial to mesenchymal transitionDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of neuron projection developmentDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of angiogenesisDisabled homolog 2-interacting proteinHomo sapiens (human)
cell motility involved in cerebral cortex radial glia guided migrationDisabled homolog 2-interacting proteinHomo sapiens (human)
layer formation in cerebral cortexDisabled homolog 2-interacting proteinHomo sapiens (human)
protein catabolic processDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of protein-containing complex assemblyDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of NF-kappaB transcription factor activityDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of toll-like receptor 4 signaling pathwayDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of GTPase activityDisabled homolog 2-interacting proteinHomo sapiens (human)
cellular response to unfolded proteinDisabled homolog 2-interacting proteinHomo sapiens (human)
tube formationDisabled homolog 2-interacting proteinHomo sapiens (human)
intracellular signal transductionDisabled homolog 2-interacting proteinHomo sapiens (human)
cellular response to vascular endothelial growth factor stimulusDisabled homolog 2-interacting proteinHomo sapiens (human)
vascular endothelial growth factor receptor-2 signaling pathwayDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of protein catabolic processDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of apoptotic processDisabled homolog 2-interacting proteinHomo sapiens (human)
regulation of GTPase activityDisabled homolog 2-interacting proteinHomo sapiens (human)
regulation of canonical NF-kappaB signal transductionDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionDisabled homolog 2-interacting proteinHomo sapiens (human)
regulation of protein-containing complex assemblyDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of MAP kinase activityDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of MAPK cascadeDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of JUN kinase activityDisabled homolog 2-interacting proteinHomo sapiens (human)
innate immune responseDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of protein catabolic processDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of DNA-templated transcriptionDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of JNK cascadeDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of Ras protein signal transductionDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of fibroblast proliferationDisabled homolog 2-interacting proteinHomo sapiens (human)
neuron projection morphogenesisDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of epithelial cell proliferationDisabled homolog 2-interacting proteinHomo sapiens (human)
regulation of cell cycleDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionDisabled homolog 2-interacting proteinHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of G0 to G1 transitionDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeDisabled homolog 2-interacting proteinHomo sapiens (human)
cellular response to lipopolysaccharideDisabled homolog 2-interacting proteinHomo sapiens (human)
cellular response to interleukin-1Disabled homolog 2-interacting proteinHomo sapiens (human)
cellular response to tumor necrosis factorDisabled homolog 2-interacting proteinHomo sapiens (human)
cellular response to epidermal growth factor stimulusDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of protein serine/threonine kinase activityDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of protein serine/threonine kinase activityDisabled homolog 2-interacting proteinHomo sapiens (human)
endothelial cell apoptotic processDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of canonical Wnt signaling pathwayDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of synapse maturationDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of dendrite developmentDisabled homolog 2-interacting proteinHomo sapiens (human)
regulation of p38MAPK cascadeDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of vascular endothelial growth factor signaling pathwayDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of proteasomal protein catabolic processDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of neuron migrationDisabled homolog 2-interacting proteinHomo sapiens (human)
positive regulation of apoptotic signaling pathwayDisabled homolog 2-interacting proteinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
signal transductionEstrogen receptor betaHomo sapiens (human)
cell-cell signalingEstrogen receptor betaHomo sapiens (human)
negative regulation of cell growthEstrogen receptor betaHomo sapiens (human)
intracellular estrogen receptor signaling pathwayEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionEstrogen receptor betaHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityEstrogen receptor betaHomo sapiens (human)
cellular response to estradiol stimulusEstrogen receptor betaHomo sapiens (human)
regulation of transcription by RNA polymerase IIEstrogen receptor betaHomo sapiens (human)
cellular response to estrogen stimulusEstrogen receptor betaHomo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayAdenylate cyclase type 10Homo sapiens (human)
epithelial cilium movement involved in extracellular fluid movementAdenylate cyclase type 10Homo sapiens (human)
glucose catabolic processAdenylate cyclase type 10Homo sapiens (human)
cAMP biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
spermatid developmentAdenylate cyclase type 10Homo sapiens (human)
positive regulation of cardiac muscle hypertrophyAdenylate cyclase type 10Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAdenylate cyclase type 10Homo sapiens (human)
negative regulation of mitochondrial membrane potentialAdenylate cyclase type 10Homo sapiens (human)
intracellular signal transductionAdenylate cyclase type 10Homo sapiens (human)
positive regulation of axon extensionAdenylate cyclase type 10Homo sapiens (human)
positive regulation of ossificationAdenylate cyclase type 10Homo sapiens (human)
positive regulation of glycogen catabolic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of mitochondrial depolarizationAdenylate cyclase type 10Homo sapiens (human)
regulation of membrane repolarizationAdenylate cyclase type 10Homo sapiens (human)
cellular response to inorganic substanceAdenylate cyclase type 10Homo sapiens (human)
neuron projection retractionAdenylate cyclase type 10Homo sapiens (human)
negative regulation of cardiac muscle cell contractionAdenylate cyclase type 10Homo sapiens (human)
regulation of mitophagyAdenylate cyclase type 10Homo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayAdenylate cyclase type 10Homo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of reactive oxygen species biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
positive regulation of protein targeting to mitochondrionAdenylate cyclase type 10Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell apoptotic processAdenylate cyclase type 10Homo sapiens (human)
neuron projection extensionAdenylate cyclase type 10Homo sapiens (human)
neuron projection maintenanceAdenylate cyclase type 10Homo sapiens (human)
mitochondrial ATP transmembrane transportAdenylate cyclase type 10Homo sapiens (human)
positive regulation of ATP biosynthetic processAdenylate cyclase type 10Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (52)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
TFIIB-class transcription factor bindingEstrogen receptorHomo sapiens (human)
transcription coregulator bindingEstrogen receptorHomo sapiens (human)
transcription corepressor bindingEstrogen receptorHomo sapiens (human)
transcription coactivator bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificEstrogen receptorHomo sapiens (human)
chromatin bindingEstrogen receptorHomo sapiens (human)
DNA-binding transcription factor activityEstrogen receptorHomo sapiens (human)
nuclear receptor activityEstrogen receptorHomo sapiens (human)
steroid bindingEstrogen receptorHomo sapiens (human)
protein bindingEstrogen receptorHomo sapiens (human)
calmodulin bindingEstrogen receptorHomo sapiens (human)
beta-catenin bindingEstrogen receptorHomo sapiens (human)
zinc ion bindingEstrogen receptorHomo sapiens (human)
TBP-class protein bindingEstrogen receptorHomo sapiens (human)
enzyme bindingEstrogen receptorHomo sapiens (human)
protein kinase bindingEstrogen receptorHomo sapiens (human)
nitric-oxide synthase regulator activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptorHomo sapiens (human)
nuclear estrogen receptor bindingEstrogen receptorHomo sapiens (human)
estrogen response element bindingEstrogen receptorHomo sapiens (human)
identical protein bindingEstrogen receptorHomo sapiens (human)
ATPase bindingEstrogen receptorHomo sapiens (human)
14-3-3 protein bindingEstrogen receptorHomo sapiens (human)
sequence-specific double-stranded DNA bindingEstrogen receptorHomo sapiens (human)
Toll-like receptor 4 bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
GTPase activator activityDisabled homolog 2-interacting proteinHomo sapiens (human)
death receptor bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
protein bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
SH3 domain bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
kinase bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
protein kinase bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
mitogen-activated protein kinase kinase bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
phosphatidylinositol-3-phosphate bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
signaling adaptor activityDisabled homolog 2-interacting proteinHomo sapiens (human)
phosphatidylinositol 3-kinase regulatory subunit bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
identical protein bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
protein homodimerization activityDisabled homolog 2-interacting proteinHomo sapiens (human)
vascular endothelial growth factor receptor 2 bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
protein serine/threonine kinase activator activityDisabled homolog 2-interacting proteinHomo sapiens (human)
phosphatidylinositol 3-kinase bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
protein-containing complex bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
cadherin bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
protein phosphatase 2A bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
phosphatidylinositol-4-phosphate bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
14-3-3 protein bindingDisabled homolog 2-interacting proteinHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingEstrogen receptor betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificEstrogen receptor betaHomo sapiens (human)
DNA bindingEstrogen receptor betaHomo sapiens (human)
nuclear steroid receptor activityEstrogen receptor betaHomo sapiens (human)
nuclear receptor activityEstrogen receptor betaHomo sapiens (human)
steroid bindingEstrogen receptor betaHomo sapiens (human)
protein bindingEstrogen receptor betaHomo sapiens (human)
zinc ion bindingEstrogen receptor betaHomo sapiens (human)
enzyme bindingEstrogen receptor betaHomo sapiens (human)
nuclear estrogen receptor activityEstrogen receptor betaHomo sapiens (human)
estrogen response element bindingEstrogen receptor betaHomo sapiens (human)
receptor antagonist activityEstrogen receptor betaHomo sapiens (human)
magnesium ion bindingAdenylate cyclase type 10Homo sapiens (human)
adenylate cyclase activityAdenylate cyclase type 10Homo sapiens (human)
ATP bindingAdenylate cyclase type 10Homo sapiens (human)
manganese ion bindingAdenylate cyclase type 10Homo sapiens (human)
ATPase bindingAdenylate cyclase type 10Homo sapiens (human)
bicarbonate bindingAdenylate cyclase type 10Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (30)

Processvia Protein(s)Taxonomy
nucleusEstrogen receptorHomo sapiens (human)
nucleoplasmEstrogen receptorHomo sapiens (human)
transcription regulator complexEstrogen receptorHomo sapiens (human)
cytoplasmEstrogen receptorHomo sapiens (human)
Golgi apparatusEstrogen receptorHomo sapiens (human)
cytosolEstrogen receptorHomo sapiens (human)
plasma membraneEstrogen receptorHomo sapiens (human)
membraneEstrogen receptorHomo sapiens (human)
chromatinEstrogen receptorHomo sapiens (human)
euchromatinEstrogen receptorHomo sapiens (human)
protein-containing complexEstrogen receptorHomo sapiens (human)
nucleusEstrogen receptorHomo sapiens (human)
cytoplasmDisabled homolog 2-interacting proteinHomo sapiens (human)
cytosolDisabled homolog 2-interacting proteinHomo sapiens (human)
plasma membraneDisabled homolog 2-interacting proteinHomo sapiens (human)
endocytic vesicleDisabled homolog 2-interacting proteinHomo sapiens (human)
axonDisabled homolog 2-interacting proteinHomo sapiens (human)
dendriteDisabled homolog 2-interacting proteinHomo sapiens (human)
neuronal cell body membraneDisabled homolog 2-interacting proteinHomo sapiens (human)
neuronal cell bodyDisabled homolog 2-interacting proteinHomo sapiens (human)
cerebellar mossy fiberDisabled homolog 2-interacting proteinHomo sapiens (human)
climbing fiberDisabled homolog 2-interacting proteinHomo sapiens (human)
parallel fiberDisabled homolog 2-interacting proteinHomo sapiens (human)
AIP1-IRE1 complexDisabled homolog 2-interacting proteinHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
nucleoplasmEstrogen receptor betaHomo sapiens (human)
mitochondrionEstrogen receptor betaHomo sapiens (human)
intracellular membrane-bounded organelleEstrogen receptor betaHomo sapiens (human)
chromatinEstrogen receptor betaHomo sapiens (human)
nucleusEstrogen receptor betaHomo sapiens (human)
microtubule cytoskeletonAdenylate cyclase type 10Homo sapiens (human)
motile ciliumAdenylate cyclase type 10Homo sapiens (human)
extracellular regionAdenylate cyclase type 10Homo sapiens (human)
nucleusAdenylate cyclase type 10Homo sapiens (human)
mitochondrionAdenylate cyclase type 10Homo sapiens (human)
cytosolAdenylate cyclase type 10Homo sapiens (human)
apical plasma membraneAdenylate cyclase type 10Homo sapiens (human)
dendriteAdenylate cyclase type 10Homo sapiens (human)
neuronal cell bodyAdenylate cyclase type 10Homo sapiens (human)
basal part of cellAdenylate cyclase type 10Homo sapiens (human)
perinuclear region of cytoplasmAdenylate cyclase type 10Homo sapiens (human)
central region of growth coneAdenylate cyclase type 10Homo sapiens (human)
astrocyte end-footAdenylate cyclase type 10Homo sapiens (human)
cytoplasmAdenylate cyclase type 10Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (39)

Assay IDTitleYearJournalArticle
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588460High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588459High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588461High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID624607Specific activity of expressed human recombinant UGT1A32000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID55149The compound was tested in vitro for its ability to initiate DNA replication1998Journal of medicinal chemistry, Apr-23, Volume: 41, Issue:9
Effect of steroids on DNA synthesis in an in vitro replication system: initial quantitative structure-activity relationship studies and construction of a non-estrogen receptor pharmacophore.
AID624618Specific activity of expressed human recombinant UGT2B42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID69064Relative induction of pS2 mRNA expression in human MCF-7 mammary carcinoma cells compared to estradiol1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation.
AID624611Specific activity of expressed human recombinant UGT1A82000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624606Specific activity of expressed human recombinant UGT1A12000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID68712Affinity estrogen receptor of MCF-7 human mammary cancer cells1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation.
AID624619Specific activity of expressed human recombinant UGT2B72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID103552Induction of pS2 mRNA expression in human MCF-7 mammary carcinoma cells1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation.
AID255211Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881)2005Journal of medicinal chemistry, Sep-08, Volume: 48, Issue:18
Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals.
AID366252Inhibition of human recombinant soluble adenylyl cyclase2008Journal of medicinal chemistry, Aug-14, Volume: 51, Issue:15
Structure-based development of novel adenylyl cyclase inhibitors.
AID624616Specific activity of expressed human recombinant UGT2B152000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624610Specific activity of expressed human recombinant UGT1A72000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID69060Relative binding affinity for estrogen receptor compared to estradiol1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
2-(Hydroxyalkyl)estradiols: synthesis and biological evaluation.
AID624613Specific activity of expressed human recombinant UGT1A102000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID624608Specific activity of expressed human recombinant UGT1A42000Annual review of pharmacology and toxicology, , Volume: 40Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
AID1224864HCS microscopy assay (F508del-CFTR)2016PloS one, , Volume: 11, Issue:10
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (317)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990136 (42.90)18.7374
1990's62 (19.56)18.2507
2000's83 (26.18)29.6817
2010's32 (10.09)24.3611
2020's4 (1.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.63 (24.57)
Research Supply Index5.78 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index25.55 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (2.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other316 (97.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]